These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 444380)

  • 1. Influence of coronary artery occlusion on the myocardial distribution of digoxin [proceedings].
    Davis MA; MacLean D; Mavoko PR
    Br J Clin Pharmacol; 1979 Apr; 7(4):431P. PubMed ID: 444380
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of coronary artery occlusion on the myocardial distribution of digoxin [proceedings].
    Roberts CJ; Marshall AJ; Heaton S; Barrit DW
    Br J Pharmacol; 1979 May; 66(1):65P. PubMed ID: 454952
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Digoxin-concentrations in ischemic heart lesions in dogs.
    Kuhlmann J; Kötter V; von Leitner E
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R52. PubMed ID: 4276592
    [No Abstract]   [Full Text] [Related]  

  • 4. Digoxin distribution in the dog's left ventricle in the presence of coronary artery ligation.
    Hopkins BE; Taylor RR; Henderson C; Burrows P
    J Mol Cell Cardiol; 1973 Apr; 5(2):197-203. PubMed ID: 4704673
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional myocardial metabolism during subtotal and total coronary artery occlusion.
    Baker LD; Bing OH; Messer JV
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():217-33. PubMed ID: 1208976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamics and metabolic determinants of distribution of myocardial flow.
    Kennedy JH; Limet R; Hwang NH; Barnett J; Schwabe L; Flasterstein A
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():491-8. PubMed ID: 1208998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of digoxin in the human heart.
    Coltart DJ; Güllner HG; Billingham M; Goldman RH; Stinson EB; Kalman SM; Harrison DC
    Postgrad Med J; 1975 May; 51(595):330-3. PubMed ID: 1215246
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional myocardial metabolism following acute coronary artery occlusion.
    Lang TW; Meerbaum S; Corday E; Costantini C; Rubins S; Cordoba M
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():295-305. PubMed ID: 1208983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular [3H]digoxin distribution after temporary myocardial ischemia in dogs.
    Ku DD
    Eur J Pharmacol; 1983 Apr; 88(4):329-38. PubMed ID: 6305674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of reduction of myocardial free fatty acid metabolism relative to that of glucose on the ischemic injury during experimental coronary artery occlusion in dogs.
    Mjos OD
    Acta Med Scand Suppl; 1976; 587():29-34. PubMed ID: 1062130
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of acute hypokalemia on the myocardial concentration and body distribution of tritiated digoxin in the dog.
    Marcus FI; Nimmo L; Kapadia GG; Goldsmith C
    J Pharmacol Exp Ther; 1971 Aug; 178(2):271-81. PubMed ID: 5570455
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of ischemia and reperfusion on myocardial uptake of tritiated digoxin.
    Beller GA; Hood WB; Smith TW
    Recent Adv Stud Cardiac Struct Metab; 1976; 9():475-85. PubMed ID: 1257585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lidocaine on the myocardial acidosis induced by coronary artery occlusion in dogs.
    Matsumura N; Matsumura H; Abiko Y
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1114-9. PubMed ID: 3656111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of digoxin on myocardial oxygen consumption in coronary heart disease].
    Tauchert M; Behrenbeck DW; Hötzel J; Jansen W; Niehues B; Hilger HH
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1641-4. PubMed ID: 611899
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of dilazep on decrease in myocardial pH during ischemia in dogs.
    Haga N; Miura I; Fujisawa Y; Fukushi Y; Abiko Y
    Arzneimittelforschung; 1986 Jun; 36(6):913-6. PubMed ID: 3741523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of glycogenolysis inhibition in the etiology of arrhythmias in coronary disease].
    Sysoliatina NA; Sapozhkov AV
    Vopr Med Khim; 1982; 28(6):56-9. PubMed ID: 7157722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion.
    Buxton DB; Mody FV; Krivokapich J; Schelbert HR
    J Mol Cell Cardiol; 1993 Jun; 25(6):667-81. PubMed ID: 8411193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nipradilol, a beta-adrenoceptor antagonist having a vasodilatory action, attenuates myocardial acidosis induced by coronary artery occlusion in dogs.
    Hino T; Hayase N; Chiba K; Ichihara K; Abiko Y
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):373-8. PubMed ID: 2568518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship between coronary artery stenosis and myocardial metabolism of oxygen demand in dogs].
    Chen SL; Zang YM; Zhu MZ; Luo BG; Liu DM; Liang H
    Sheng Li Xue Bao; 1989 Jun; 41(3):272-7. PubMed ID: 2781311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of cardiac structural proteins induced by reperfusion in the infarcted myocardium.
    Tsuchida K; Kaneko K; Yamazaki R; Aihara H
    Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):195-202. PubMed ID: 3764082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.